Unified Patent Court (UPC) analytics are now available. Check here

EP2506857

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP10835016A
Filing Date
Nov 30, 2010
Status
Revoked
May 4, 2024
Grant Date
Feb 14, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2506857B1 was granted on Feb 14, 2018 by Shire Human Genetic Therapies The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRADYNov 14, 2018ADMISSIBLE
WITHERS & ROGERSNov 14, 2018ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2005120152
N/A
OppositionUS5580859
N/A
OppositionWO9011092
N/A
OppositionWO9851278
N/A
OppositionWO9918933
N/A
OppositionWO2009086558
N/A
OppositionUS5912159
N/A
OppositionUS6077835
N/A
OppositionEP1026253
N/A
OppositionUS6734171
N/A
OppositionWO2007024708
N/A
OppositionWO2008052770
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.